COMMUNIQUÉS West-GlobeNewswire

Virbac : Déclaration d'actions et de droits de vote 09/2019
01/10/2019
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
SuperSonic Imagine Innovates in Ultrasound with Its New Liver Markers
01/10/2019
A suite of three new tools is available on Aixplorer MACH 30 ultrasound platform AIX-EN-PROVENCE, France, Oct. 01, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814), a company specializing in [...]
Information on total number of voting rights and shares composing the share capital as at September 30, 2019
01/10/2019
Paris, October 1 st , 2019 – 6.00PM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronic company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent [...]
Information relative au nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2019
01/10/2019
Paris, le 1 er octobre 2019 – 18 :00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue, de vivre de [...]
Single-Inhaler Extrafine Triple Therapy of Inhaled Corticosteroid, Long-Acting B2-Agonist and Long-Acting Muscarinic Antagonist Therapy Improves Lung Function and Reduces Asthma Exacerbations(1)
01/10/2019
Data from two randomized, double-blind, parallel-group, active-controlled studies on the efficacy and safety of single-inhaler triple therapy in adult patients with uncontrolled asthma is published in The Lancet for the [...]
Cheetah Medical Presents Update on FRESH Clinical Trial at the European Society of Intensive Care Medicine 32nd Annual Congress
01/10/2019
NEWTON, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Cheetah Medical, a medical device leader in non-invasive fluid management technology, presented today at the European Society of Intensive Care Medicine (ESICM) Annual [...]
The Dr.Quay.com Website and ElevatorMedicine™ Launch to Promote Breast Cancer Awareness Month
01/10/2019
SEATTLE, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Dr. Steven Quay, MD, PhD, is proud to announce today his participation in National Breast Cancer Awareness Month with the launch of his new website, www.DrQuay.com , dedicated [...]
CV Sciences, Inc. Announces Distribution Partnership With Harris Teeter
01/10/2019
Partnership Broadens Distribution of PlusCBD™ Oil Products to 150 Harris Teeter Locations SAN DIEGO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), [...]
UPDATE -- Smile Direct Club to Report Third Quarter 2019 Financial Results on November 12, 2019
01/10/2019
NASHVILLE, Tenn., Oct. 01, 2019 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ: SDC) (“SmileDirectClub”), the industry pioneer and first direct-to-consumer medtech platform for transforming smiles, announced today it [...]
Introducing Sante Laboratories
01/10/2019
Texas’ First ISO Accredited Laboratory Focused on Delivering Confidence and Access to the Hemp and CBD Testing Industry AUSTIN, Texas, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Today marks the grand opening of Sante [...]
'Making the grade' on campus mental health with new training for post-secondary students
01/10/2019
From Mental Health Commission of Canada OTTAWA, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Today the Mental Health Commission of Canada (MHCC), in partnership with the University of Calgary, officially launched a new mental [...]
« Réussir le test » sur la santé mentale sur les campus à la suite d’une nouvelle formation pour les étudiants du postsecondaire
01/10/2019
De la Commission de la santé mentale du Canada OTTAWA, 01 oct. 2019 (GLOBE NEWSWIRE) -- Aujourd’hui, la Commission de la santé mentale du Canada (CSMC), en partenariat avec l’Université de Calgary, a officiellement [...]
Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
01/10/2019
Multiyear alliance underpins the Novartis commitment to leverage data & Artificial Intelligence (AI) to transform how medicines are discovered, developed and commercialized Novartis to establish AI innovation lab to [...]
NOTICE TO CONVENE EXTRAORDINARY GENERAL MEETING
01/10/2019
INDKALDELSE TIL EKSTRAORDINÆR GENERALFORSAMLING KALLELSE TILL EXTRA BOLAGSSTÄMMA Der indkaldes herved til ekstraordinær generalforsamling i Oncology Venture A/S (“ Selskabet “), som afholdes: Notice is hereby given that [...]
Generex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled Syringe
01/10/2019
MIRAMAR, Fla., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) ( GNBT ) ( http://www.otcmarkets.com/stock/GNBT/quote ), is pleased to announce that their subsidiary, Olaregen [...]
Evolus Receives Approval for Nuceiva™ in the European Union
01/10/2019
NEWPORT BEACH, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that the [...]
BrainsWay Announces Innovative Deep Transcranial Magnetic Stimulation System Showcase Presentation at this Year’s Psych Congress Meeting
01/10/2019
JERUSALEM, Oct. 01, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ: BWAY, TASE: BWAY), a global leader in the advanced non-invasive treatment of brain disorders, announced today they will be hosting “Advances in [...]
Adamis Pharmaceuticals Announces Commercial Partnership with Emerge Health for SYMJEPI® in Australia and New Zealand
01/10/2019
SAN DIEGO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today that it has entered into an exclusive distribution and commercialization agreement with Emerge Health Pty (“ [...]
Acasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
01/10/2019
LAVAL, Québec, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]

Pages